1er Symposium canadien sur la COVID LONGUE
Prof. Dr. med. Carmen Scheibenbogen
-
Bereich Immundefekte und Postinfektiöse Erkrankungen
-
Institut für Med. Immunologie | Charité
Simon Schoening
-
Scientific Coordinator
-
ME/CFS Research Foundation
Moderator:
Susan Law, PhD
-
Knowledge Mobilization Lead, Long COVID Web
-
Associate Professor, Institute of Health Policy, Management and Evaluation
Session Overview: This presentation will give an overview of the National Clinical Trial Network (NKSG) and its translational approach to developing targeted therapies for ME/CFS and other post-acute infection syndromes. My focus will be on antibody-targeting therapies, ranging from immunoadsorption to B-cell- and plasma-cell-targeted therapies.
Attendees will have an opportunity to ask questions of the speakers following their presentations.